Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy

Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy Review Abstract Purpose: This paper examines current approaches to lipid management in family practice, focusing on risk stratification methods, the role of coronary artery calcium scoring, and implementation of

The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden

The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden Review Abstract Lipidology is undergoing a clinically important transition from traditional cholesterol-centered assessment toward a more precise evaluation of atherogenic lipoprotein burden. Low-density lipoprotein cholesterol (LDL-C) remains a validated therapeutic target

Microplastics in Coffee Pods: Current Evidence and Potential Health Implications

Microplastics in Coffee Pods: Current Evidence and Potential Health Implications Key Takeaways Research reveals alarming levels of microplastic contamination in single-use coffee pods, with significant health implications for daily coffee drinkers and actionable solutions available. • A single plastic coffee pod can release over

The Hidden Burden of Subclinical Hypothyroidism: When to Treat and When to Watch

The Hidden Burden of Subclinical Hypothyroidism: When to Treat and When to Watch Check back later for a possible video summary. Videos are created for most articles.   Abstract Background:Subclinical hypothyroidism (SCH) is defined by elevated serum thyroid-stimulating hormone (TSH) levels alongside normal free thyroxine

Polypills for Cardiovascular Disease Prevention: Smart Innovation or Oversimplification?

Polypills for Cardiovascular Disease Prevention: Smart Innovation or Oversimplification? Check back later for a possible video summary. Videos are created for most articles. Abstract The polypill, a fixed-dose combination of multiple cardiovascular medications in a single pill, represents a major shift in

Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?

Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?   Introduction Cardiovascular disease (CVD) remains the leading cause of death for most racial and ethnic groups, with cholesterol guidelines playing a crucial role in prevention strategies. Dyslipidemia stands

Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy